Analysen von Olivier Calvet

29.05.26		CTS Eventim Buy	UBS AG
20.05.26		CTS Eventim Buy	UBS AG
13.05.26		SCHOTT Pharma Buy	UBS AG
06.05.26		RATIONAL Buy	UBS AG
01.05.26		Befesa Buy	UBS AG
30.04.26		Befesa Buy	UBS AG
23.04.26		Befesa Buy	UBS AG
30.03.26		CTS Eventim Buy	UBS AG
Werbung
20.03.26		RATIONAL Buy	UBS AG
19.03.26		CTS Eventim Buy	UBS AG
19.03.26		Befesa Buy	UBS AG
19.03.26		RATIONAL Buy	UBS AG
02.03.26		Befesa Buy	UBS AG
26.02.26		Befesa Buy	UBS AG
18.02.26		Befesa Buy	UBS AG
12.02.26		SCHOTT Pharma Buy	UBS AG
12.02.26		Befesa Buy	UBS AG
11.02.26		SCHOTT Pharma Buy	UBS AG
05.02.26		RATIONAL Buy	UBS AG
04.02.26		CTS Eventim Buy	UBS AG
18.12.25		RATIONAL Buy	UBS AG
12.12.25		SCHOTT Pharma Buy	UBS AG
12.12.25		SCHOTT Pharma Buy	UBS AG
05.12.25		SCHOTT Pharma Buy	UBS AG
21.11.25		CTS Eventim Buy	UBS AG
06.11.25		CTS Eventim Buy	UBS AG
31.10.25		Befesa Buy	UBS AG
30.10.25		Befesa Buy	UBS AG
28.10.25		Befesa Buy	UBS AG
09.10.25		Gerresheimer Buy	UBS AG
08.10.25		CTS Eventim Buy	UBS AG
19.09.25		Befesa Buy	UBS AG
22.08.25		CTS Eventim Buy	UBS AG
21.08.25		CTS Eventim Buy	UBS AG
12.08.25		SCHOTT Pharma Buy	UBS AG
05.08.25		SCHOTT Pharma Buy	UBS AG
22.05.25		CTS Eventim Buy	UBS AG
20.05.25		SCHOTT Pharma Buy	UBS AG
23.04.25		SCHOTT Pharma Buy	UBS AG
23.04.25		Gerresheimer Buy	UBS AG
11.04.25		Gerresheimer Buy	UBS AG
11.04.25		SCHOTT Pharma Buy	UBS AG
31.03.25		CTS Eventim Buy	UBS AG
27.03.25		CTS Eventim Buy	UBS AG
25.03.25		JENOPTIK Buy	UBS AG
19.03.25		Gerresheimer Buy	UBS AG
06.03.25		SCHOTT Pharma Buy	UBS AG
26.02.25		Gerresheimer Buy	UBS AG
24.02.25		CTS Eventim Buy	UBS AG
24.02.25		SCHOTT Pharma Buy	UBS AG